HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical profile and practice experience of almotriptan.

Abstract
Patients expect their acute migraine treatment to have a rapid onset of action, achieve complete pain relief that is sustained for 24 h, and to have a good tolerability profile. Almotriptan has a favourable pharmacokinetic profile that translates clinically to a rapid onset of action and consistent absorption regardless of age, sex, food intake and status of the acute migraine attack. In addition, almotriptan is not associated with any clinically relevant drug-drug interactions. Pain-free status at 2 h postdose is achieved by approximately 39% of patients receiving almotriptan in clinical trials. Recurrence of headaches within 24 h is low with almotriptan (<22%). Almotriptan has a sustained pain-free rate of 25-27%, which in a meta-analysis of triptans was superior to sumatriptan 100 mg. Almotriptan therapy is associated with a low incidence of adverse events, including those affecting the central nervous system and chest.
AuthorsA Gendolla
JournalCephalalgia : an international journal of headache (Cephalalgia) Vol. 24 Suppl 2 Pg. 16-23 ( 2004) ISSN: 0333-1024 [Print] England
PMID15595990 (Publication Type: Journal Article, Review)
Chemical References
  • Analgesics
  • Indoles
  • Serotonin Receptor Agonists
  • Tryptamines
  • almotriptan
Topics
  • Acute Disease
  • Analgesics (adverse effects, therapeutic use)
  • Attitude to Health
  • Clinical Trials as Topic
  • Disease Progression
  • Humans
  • Indoles (adverse effects, therapeutic use)
  • Migraine Disorders (diagnosis, drug therapy, epidemiology, prevention & control)
  • Patient Satisfaction
  • Practice Patterns, Physicians'
  • Secondary Prevention
  • Serotonin Receptor Agonists (therapeutic use)
  • Treatment Outcome
  • Tryptamines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: